Anoril-D (60 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Stalwart Remedies Pvt. Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Chlorpheniramine Maleate, Dextromethorphan Hydrobromide,Phenylpropanolamine HCL. This drug comes in the form of Syrup. The general packing available for this medicine consists of 60 ml and is priced at Rs 26 (arround $0.364 US Dollar)
The main active ingredients or salts in Anoril-D (60 ml) are :
Chlorpheniramine Maleate-2 mg
Dextromethorphan Hydrobromide-10 mg
Phenylpropanolamine HCL-12.5 mg
Chlorpheniramine Maleate Indication (Prescribed for or used as): Allergic conditions. Adjunct in the emergency treatment of anaphylactic shock.
For more details on Chlorpheniramine Maleate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Chlorpheniramine Maleate..
Dextromethorphan Hydrobromide Indication (Prescribed for or used as):
For more details on Dextromethorphan Hydrobromide, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Dextromethorphan Hydrobromide..
Phenylpropanolamine HCL Indication (Prescribed for or used as):
For more details on Phenylpropanolamine HCL, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Phenylpropanolamine HCL..
Anoril-D (60 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 15 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Anoril-D (60 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Chlorpheniramine Maleate-2 mg Dextromethorphan Hydrobromide-10 mg Phenylpropanolamine HCL-12.5 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.